Exhibit 99.1 Bristol Myers Squibb Reports Second Quarter Financial Results for 2026 and Raises Full- Year Outlook Strong Performance Underscores Growth Portfolio Momentum and Pipeline Progress (PRINCETON, N.J., July 30, 2026) – Bristol Myers Squibb (NYSE: BMY) today reports results for the second quarter of 2026. "The Growth Portfolio continues to deliver, achieving 15% growth in the quarter, and represents an expanding share of our overall business," said Christopher Boerner, Ph.D., board chair and chief e ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39094 PHATHOM PHARMACEUTICALS, INC. (Exact name of Registrant as specified in its charter) Delaware 82-4151574 (State or other jurisdicti ...

Exhibit 99.1 Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results Data presented at AACR and ASCO provide further validation of the potential of Bicycle technology to deliver oncology therapeutics with improved benefit/risk profiles compared to existing modalities Expanded Clinical Advisory Board with the addition of Thomas Powles, MBBS, MRCP, M.D. Cash and cash equivalents of $510.1 million as of June 30, 2026, with expected cash runway into 2030 CAMBRIDGE, Englan ...

Exhibit 10.1 EXECUTION COPY AMENDMENT NO. 2 Dated as of July 28, 2026 to SEVENTH AMENDED AND RESTATED LOAN AGREEMENT Dated as of September 29, 2022 THIS AMENDMENT NO. 2 (this "Amendment") is made as of July 28, 2026 by and among Myers Industries, Inc., an Ohio corporation (the "Company"), MYE Canada Operations Inc. ("MYE Canada"), Scepter Canada Inc. ("Scepter" and, together with MYE Canada, the "Foreign Subsidiary Borrowers" and, together with the Company, the "Borrowers"), the financial institutions liste ...

Exhibit 99.1 Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update FLORHAM PARK, N.J., July 30, 2026 — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, today reported financial results for the second quarter ended June 30, 2026, and provided a business update. "The second quarter marked an important milestone for Phathom as we delivered strong q ...

广东联泰环保股份有限公司2026 年半年度报告 公司代码：603797 公司简称：联泰环保 广东联泰环保股份有限公司 2026 年半年度报告 1 / 186 广东联泰环保股份有限公司2026 年半年度报告 重要提示 一、 本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人黄建勲、主管会计工作负责人杨基华及会计机构负责人（会计主管人员）杨 基华声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的经济和产业发展形势、未来计划、发展战略等前瞻性陈述不构成公司对投 资者的实质承诺，请投资者注意风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、 重大风险提示 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-38860 TRADEWEB MARKETS INC. (Exact name of registrant as specified in its charter) ___________________________________________ (State or other jurisdiction ...

Terex Reports Second Quarter 2026 Results Norwalk, CT, July 30, 2026 -- Terex Corporation (NYSE: TEX), a global leader in specialized equipment, serving essential sectors such as emergency services, waste and recycling, utilities, and construction, today announced its results for the second quarter 2026. CEO Commentary "Terex delivered a strong second quarter, with revenue growth in all segments, improved profitability, and positive booking trends that reflect healthy demand across much of the portfolio," s ...

July 30, 2026 ▷ PGY Q2 Letter to Shareholders CE Our record quarter reflects a flywheel that is clearly working: partners are sending more volume, adopting more products, and our network effects compound with every relationship we add. Gal Krubiner Co-Founder & CEO $387M Total revenue and other income of $387 million compared to our outlook of $345 - $365 million and grew 19% year-over-year, driven by growth in fee revenue and interest income. Q2 Financial Highlights $3.5B Network volume of $3.5 billion com ...

AMC GLOBAL MEDIA INC. REPORTS SECOND QUARTER 2026 RESULTS New York, NY – July 30, 2026: AMC Global Media Inc. ("AMC Global Media" or the "Company") (NASDAQ: AMCX) today reported financial results for the second quarter ended June 30, 2026. Chief Executive Officer Kristin Dolan said: "We are pleased to announce today an expansion of our relationship with a key long- term partner, Netflix. We have reached a global co-exclusive licensing agreement for the streaming rights to the entire Walking Dead Universe, w ...